Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Lorena Appio"'
Autor:
Giovanni Serio, Lorena Appio, Elisabetta Vassenna, Martina Chiarucci, Carlo Landoni, Marco Bregni, Vanda Bertolli, Giovanni Crovetti, Maria La Targia
Publikováno v:
Chemotherapy. 62(3)
Aggressive non-Hodgkin lymphoma is associated with poor long-term survival after relapse or resistance to chemotherapy. We report a case of aggressive non-Hodgkin lymphoma refractory to first-line R-CHOP (rituximab, cyclophosphamide, doxorubicin, vin
Publikováno v:
Hematology/Oncology Clinics of North America. 24:709-716
VTE can be considered as a multicausal disease involving various inherited and acquired prothrombotic conditions. Although greater emphasis has classically been given to traditional thrombophilic risk factors, there is increasing recognition of less
Publikováno v:
Journal of Thrombosis and Haemostasis. 7:722-725
Autor:
Margherita Maffioli, Francesco Passamonti, Domenica Caramazza, Claudia Basilico, Lorena Appio, Luca Arcaini, A. Ferrario, Michele Merli
Indolent non-Hodgkin’s lymphomas (iNHLs) include follicular lymphomas (FL), marginal-zone lymphoma, lymphoplasmacytic lymphoma/Waldenström macroglobulinemia and small lymphocytic lymphoma. First-line standard therapy in advanced, symptomatic iNHL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbf5307b33e7c5b5e8b556c44aaea720
https://europepmc.org/articles/PMC3629754/
https://europepmc.org/articles/PMC3629754/
JAK2 is a tyrosine kinase that plays an important role in the signaling pathways of many hematopoietic growth factor receptors. A single acquired point mutation – V617F – in JAK2 occurs in the great majority of patients with polycythemia vera (PV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a19a42f7e6e9f4b7d9e09c431f89fde3
http://hdl.handle.net/11383/1717225
http://hdl.handle.net/11383/1717225
Autor:
Alessandro Squizzato, Mark Crowther, Walter Ageno, Lorenza Brivio, Leonardo Campiotti, Lorena Appio, Anna Maria Grandi, Francesco Dentali
Recent studies suggested that JAK2V617F mutation is frequent in patients with splanchnic vein thrombosis (SVT) but not in patients with other venous thromboembolic events (VTE). However, whether screening for the JAK2V617F mutation in VTE patients is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c632d1fa4276df745454077ddef50e68
http://hdl.handle.net/11383/1706310
http://hdl.handle.net/11383/1706310
Autor:
Achille Venco, R. Casalone, Francesco Solbiati, R. Righi, Lorena Appio, Leonardo Campiotti, Walter Ageno, Anna Maria Grandi
Publikováno v:
Leukemialymphoma. 49(3)
The classification of acute myeloid leukemia (AML) recognizes a subgroup of diseases with recurring genetic abnormalities. Translocation (15;17) is the marker of acute promyelocitic leukemia (APL) ...
Autor:
Silvia Uccella, Carlo Capella, Stefano La Rosa, Leonardo Campiotti, Lorena Appio, Achille Venco, Francesco Pallotti
Publikováno v:
Leukemia Research. 33:e166-e167